| Entry |
|
|---|
| Name |
Cadralazine (JP18/INN);
Cadral (TN) |
|---|
| Formula |
C12H21N5O3
|
|---|
| Exact mass |
283.1644
|
|---|
| Mol weight |
283.3268
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
|
|---|
| Remark |
|
|---|
| Efficacy |
Antihypertensive |
|---|
| Comment |
Hydrazinophthalazine derivative
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C02 ANTIHYPERTENSIVES
C02D ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON
C02DB Hydrazinophthalazine derivatives
C02DB04 Cadralazine
D01804 Cadralazine (JP18/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG02046 Hydrazinophthalazine derivative
D01804 Cadralazine
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01804 Cadralazine
D01804 Cadralazine tablets
|
|---|
| Other DBs |
|
|---|
| KCF data |
ATOM 20
1 C8x C 20.9644 -10.4655
2 C8y C 20.9644 -11.8675
3 N5x N 19.7474 -12.5684
4 N5x N 18.5374 -11.8675
5 C8y C 18.5374 -10.4655
6 C8x C 19.7474 -9.7645
7 N1b N 17.3321 -9.7715
8 N1c N 22.1752 -12.5684
9 C1b C 23.3860 -11.8675
10 C1c C 24.5968 -12.5684
11 C1a C 25.8076 -11.8675
12 C1b C 22.1752 -13.9704
13 C1a C 20.9612 -14.6714
14 O1a O 24.5968 -13.9704
15 N1b N 16.1213 -10.4725
16 C7a C 14.9105 -9.7715
17 O7a O 13.6997 -10.4725
18 C1b C 12.4889 -9.7715
19 C1a C 11.2781 -10.4725
20 O6a O 14.9105 -8.3695
BOND 20
1 9 10 1
2 4 5 1
3 10 11 1
4 5 6 2
5 8 12 1
6 6 1 1
7 12 13 1
8 10 14 1
9 5 7 1
10 7 15 1
11 1 2 2
12 15 16 1
13 2 8 1
14 16 17 1
15 2 3 1
16 17 18 1
17 8 9 1
18 18 19 1
19 3 4 2
20 16 20 2
|
|---|
